AVGO
54
12
VIX
22
-14
CRM
70
18
EQIX
64
5
ACN
56
2
A
43
-5
CNX
49
3
ALLE
44
3
CME
45
3
AEE
51
-7
AZO
42
-3
BK
74
5
CFG
95
2
BEN
55
2
ABBV
59
13
ADM
47
2
AME
72
6
BA
47
4
CMI
71
2
AKAM
64
2
AVGO
54
12
VIX
22
-14
CRM
70
18
EQIX
64
5
ACN
56
2
A
43
-5
CNX
49
3
ALLE
44
3
CME
45
3
AEE
51
-7
AZO
42
-3
BK
74
5
CFG
95
2
BEN
55
2
ABBV
59
13
ADM
47
2
AME
72
6
BA
47
4
CMI
71
2
AKAM
64
2
Financhill
Back

Ares Dynamic Credit Allocation Fund Vs. Novo Nordisk A/S Industry Stock Comparison

Sell
32

ARDC
Ares Dynamic Credit Allocation Fund

Last Price:
$13.28
Seasonality Move:
2.32%
Sell
20

NVO
Novo Nordisk A/S

Last Price:
$48.11
Seasonality Move:
4.04%
Sell
32
Ares Dynamic Credit Allocation Fund (ARDC) is a Sell

Is Ares Dynamic Credit Allocation Fund a Buy, Sell or Hold?

  • The current Ares Dynamic Credit Allocation Fund [ARDC] share price is $13.27. The Score for ARDC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ARDC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Novo Nordisk A/S (NVO) is a Sell

Is Novo Nordisk A/S a Buy, Sell or Hold?

  • The current Novo Nordisk A/S [NVO] share price is $48.09. The Score for NVO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ARDC Stock Price Chart

What is Ares Dynamic Credit Allocation Fund's stock price today?

  • The Ares Dynamic Credit Allocation Fund share price today is $13.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARDC is experiencing selling pressure, which indicates risk of future bearish movement.

NVO Stock Price Chart

What is Novo Nordisk A/S's stock price today?

  • The Novo Nordisk A/S share price today is $48.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

ARDC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 33.77 Sell
Chaikin Money Flow: -148885 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.32 - 13.62) Sell
Bollinger Bands (100): (13.47 - 14.53) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 46.95 Sell
Chaikin Money Flow: -7995446 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.92 - 49.34) Sell
Bollinger Bands (100): (48.13 - 56.93) Sell

ARDC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.35 Sell
20-day SMA: 13.42 Sell
50-day SMA: 13.55 Sell
200-day SMA: 13.99 Sell
8-day EMA: 13.34 Sell
20-day EMA: 13.43 Sell
50-day EMA: 13.61 Sell
200-day EMA: 14.05 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.04 Sell
20-day SMA: 48.12 Sell
50-day SMA: 50 Sell
200-day SMA: 60.88 Sell
8-day EMA: 48.42 Sell
20-day EMA: 48.52 Sell
50-day EMA: 50.22 Sell
200-day EMA: 63.1 Sell

Ares Dynamic Credit Allocation Fund Earnings Growth & ARDC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk A/S Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.16 per share.

Ares Dynamic Credit Allocation Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):